img

Global and United States Oral Anti-allergic Drugs Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Oral Anti-allergic Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Oral Anti-allergic Drugs Market
This report focuses on global and United States Oral Anti-allergic Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Oral Anti-allergic Drugs revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Oral Anti-allergic Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Oral Anti-allergic Drugs include Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer and AstraZeneca, etc. The global five biggest players hold a share of % in 2024.
Global Oral Anti-allergic Drugs Scope and Market Size
Oral Anti-allergic Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Oral Anti-allergic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Oral Anti-allergic Drugs market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Sanofi
Johnson & Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Almirall
Pfizer
AstraZeneca
Sun Pharma
Novartis
Boehringer Ingelheim
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays Pharma
Segment by Type
Antihistamine Drugs
Allergic Mediator Release Agent
Immunosuppressant Drugs

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Oral Anti-allergic Drugs definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Oral Anti-allergic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Oral Anti-allergic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Anti-allergic Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Oral Anti-allergic Drugs Product Introduction
1.2 Global Oral Anti-allergic Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Oral Anti-allergic Drugs Sales in US$ Million for the Year 2018-2034
1.2.2 Global Oral Anti-allergic Drugs Sales in Volume for the Year 2018-2034
1.3 United States Oral Anti-allergic Drugs Outlook 2018 VS 2024 VS 2034
1.3.1 United States Oral Anti-allergic Drugs Sales in US$ Million for the Year 2018-2034
1.3.2 United States Oral Anti-allergic Drugs Sales in Volume for the Year 2018-2034
1.4 Oral Anti-allergic Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Oral Anti-allergic Drugs in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Oral Anti-allergic Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Oral Anti-allergic Drugs Market Dynamics
1.5.1 Oral Anti-allergic Drugs Industry Trends
1.5.2 Oral Anti-allergic Drugs Market Drivers
1.5.3 Oral Anti-allergic Drugs Market Challenges
1.5.4 Oral Anti-allergic Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Oral Anti-allergic Drugs by Type
2.1 Oral Anti-allergic Drugs Market Segment by Type
2.1.1 Antihistamine Drugs
2.1.2 Allergic Mediator Release Agent
2.1.3 Immunosuppressant Drugs
2.2 Global Oral Anti-allergic Drugs Market Size by Type
2.2.1 Global Oral Anti-allergic Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Oral Anti-allergic Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Oral Anti-allergic Drugs Market Size by Type
2.3.1 United States Oral Anti-allergic Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Oral Anti-allergic Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Oral Anti-allergic Drugs by Application
3.1 Oral Anti-allergic Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Oral Anti-allergic Drugs Market Size by Application
3.2.1 Global Oral Anti-allergic Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Oral Anti-allergic Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Oral Anti-allergic Drugs Market Size by Application
3.3.1 United States Oral Anti-allergic Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Oral Anti-allergic Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Oral Anti-allergic Drugs Competitor Landscape by Company
4.1 Global Oral Anti-allergic Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Oral Anti-allergic Drugs, Ranked by Revenue (2024)
4.1.2 Global Oral Anti-allergic Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Oral Anti-allergic Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Oral Anti-allergic Drugs Price by Manufacturer (2018-2023)
4.2 Global Oral Anti-allergic Drugs Concentration Ratio (CR)
4.2.1 Oral Anti-allergic Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Anti-allergic Drugs in 2024
4.2.3 Global Oral Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Oral Anti-allergic Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Oral Anti-allergic Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Oral Anti-allergic Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Oral Anti-allergic Drugs Market Size by Company
4.7.1 Key Players of Oral Anti-allergic Drugs in United States, Ranked by Revenue (2024)
4.7.2 United States Oral Anti-allergic Drugs Revenue by Players (2018-2023)
4.7.3 United States Oral Anti-allergic Drugs Sales by Players (2018-2023)
5 Global Oral Anti-allergic Drugs Market Size by Region
5.1 Global Oral Anti-allergic Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Oral Anti-allergic Drugs Market Size in Volume by Region (2018-2034)
5.2.1 Global Oral Anti-allergic Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Oral Anti-allergic Drugs Sales in Volume Forecast by Region (2024-2034)
5.3 Global Oral Anti-allergic Drugs Market Size in Value by Region (2018-2034)
5.3.1 Global Oral Anti-allergic Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Oral Anti-allergic Drugs Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Oral Anti-allergic Drugs Market Size YoY Growth 2018-2034
6.2 Americas Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Oral Anti-allergic Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Oral Anti-allergic Drugs Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Oral Anti-allergic Drugs Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Oral Anti-allergic Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Oral Anti-allergic Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Oral Anti-allergic Drugs Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Oral Anti-allergic Drugs Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Oral Anti-allergic Drugs Market Size YoY Growth 2018-2034
8.2 China Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Oral Anti-allergic Drugs Market Size YoY Growth 2018-2034
9.2 APAC Oral Anti-allergic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Oral Anti-allergic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Oral Anti-allergic Drugs Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Oral Anti-allergic Drugs Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Oral Anti-allergic Drugs Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Description and Business Overview
10.1.3 Sanofi Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Oral Anti-allergic Drugs Products Offered
10.1.5 Sanofi Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Description and Business Overview
10.2.3 Johnson & Johnson Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Oral Anti-allergic Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Description and Business Overview
10.3.3 Merck Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Oral Anti-allergic Drugs Products Offered
10.3.5 Merck Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Description and Business Overview
10.4.3 Teva Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Oral Anti-allergic Drugs Products Offered
10.4.5 Teva Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Description and Business Overview
10.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Description and Business Overview
10.6.3 Bayer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Oral Anti-allergic Drugs Products Offered
10.6.5 Bayer Recent Development
10.7 Almirall
10.7.1 Almirall Company Information
10.7.2 Almirall Description and Business Overview
10.7.3 Almirall Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Almirall Oral Anti-allergic Drugs Products Offered
10.7.5 Almirall Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Description and Business Overview
10.8.3 Pfizer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Oral Anti-allergic Drugs Products Offered
10.8.5 Pfizer Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Description and Business Overview
10.9.3 AstraZeneca Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AstraZeneca Oral Anti-allergic Drugs Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Sun Pharma
10.10.1 Sun Pharma Company Information
10.10.2 Sun Pharma Description and Business Overview
10.10.3 Sun Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sun Pharma Oral Anti-allergic Drugs Products Offered
10.10.5 Sun Pharma Recent Development
10.11 Novartis
10.11.1 Novartis Company Information
10.11.2 Novartis Description and Business Overview
10.11.3 Novartis Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Novartis Oral Anti-allergic Drugs Products Offered
10.11.5 Novartis Recent Development
10.12 Boehringer Ingelheim
10.12.1 Boehringer Ingelheim Company Information
10.12.2 Boehringer Ingelheim Description and Business Overview
10.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Products Offered
10.12.5 Boehringer Ingelheim Recent Development
10.13 UCB Pharma
10.13.1 UCB Pharma Company Information
10.13.2 UCB Pharma Description and Business Overview
10.13.3 UCB Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 UCB Pharma Oral Anti-allergic Drugs Products Offered
10.13.5 UCB Pharma Recent Development
10.14 Yangtze River Pharmaceutical Group
10.14.1 Yangtze River Pharmaceutical Group Company Information
10.14.2 Yangtze River Pharmaceutical Group Description and Business Overview
10.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Products Offered
10.14.5 Yangtze River Pharmaceutical Group Recent Development
10.15 Hainan Poly Pharm
10.15.1 Hainan Poly Pharm Company Information
10.15.2 Hainan Poly Pharm Description and Business Overview
10.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Products Offered
10.15.5 Hainan Poly Pharm Recent Development
10.16 Chongqing Huapont Pharmaceutical
10.16.1 Chongqing Huapont Pharmaceutical Company Information
10.16.2 Chongqing Huapont Pharmaceutical Description and Business Overview
10.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Products Offered
10.16.5 Chongqing Huapont Pharmaceutical Recent Development
10.17 Dawnrays Pharma
10.17.1 Dawnrays Pharma Company Information
10.17.2 Dawnrays Pharma Description and Business Overview
10.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Products Offered
10.17.5 Dawnrays Pharma Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Oral Anti-allergic Drugs Industry Chain Analysis
11.2 Oral Anti-allergic Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Oral Anti-allergic Drugs Production Mode & Process
11.4 Oral Anti-allergic Drugs Sales and Marketing
11.4.1 Oral Anti-allergic Drugs Sales Channels
11.4.2 Oral Anti-allergic Drugs Distributors
11.5 Oral Anti-allergic Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Oral Anti-allergic Drugs CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Oral Anti-allergic Drugs Market Trends
Table 3. Oral Anti-allergic Drugs Market Drivers
Table 4. Oral Anti-allergic Drugs Market Challenges
Table 5. Oral Anti-allergic Drugs Market Restraints
Table 6. Global Oral Anti-allergic Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Oral Anti-allergic Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Oral Anti-allergic Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Oral Anti-allergic Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Oral Anti-allergic Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Oral Anti-allergic Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Oral Anti-allergic Drugs Revenue Share by Manufacturer, 2018-2023
Table 13. Global Oral Anti-allergic Drugs Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Oral Anti-allergic Drugs Sales Share by Manufacturer, 2018-2023
Table 15. Global Oral Anti-allergic Drugs Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Oral Anti-allergic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oral Anti-allergic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-allergic Drugs as of 2024)
Table 18. Global Key Manufacturers of Oral Anti-allergic Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Oral Anti-allergic Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of Oral Anti-allergic Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Oral Anti-allergic Drugs in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Oral Anti-allergic Drugs Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Oral Anti-allergic Drugs Revenue Share by Players, (2018-2023)
Table 25. United States Oral Anti-allergic Drugs Sales by Players, (K Units), (2018-2023)
Table 26. United States Oral Anti-allergic Drugs Sales Share by Players, (2018-2023)
Table 27. Global Oral Anti-allergic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Oral Anti-allergic Drugs Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Oral Anti-allergic Drugs Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Oral Anti-allergic Drugs Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Oral Anti-allergic Drugs Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Oral Anti-allergic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Oral Anti-allergic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Oral Anti-allergic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Oral Anti-allergic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Oral Anti-allergic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Oral Anti-allergic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Oral Anti-allergic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Oral Anti-allergic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Oral Anti-allergic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Oral Anti-allergic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Oral Anti-allergic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Oral Anti-allergic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Oral Anti-allergic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Oral Anti-allergic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Oral Anti-allergic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Sanofi Company Information
Table 48. Sanofi Description and Business Overview
Table 49. Sanofi Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Sanofi Oral Anti-allergic Drugs Product
Table 51. Sanofi Recent Development
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Johnson & Johnson Oral Anti-allergic Drugs Product
Table 56. Johnson & Johnson Recent Development
Table 57. Merck Company Information
Table 58. Merck Description and Business Overview
Table 59. Merck Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Merck Oral Anti-allergic Drugs Product
Table 61. Merck Recent Development
Table 62. Teva Company Information
Table 63. Teva Description and Business Overview
Table 64. Teva Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Teva Oral Anti-allergic Drugs Product
Table 66. Teva Recent Development
Table 67. GlaxoSmithKline Company Information
Table 68. GlaxoSmithKline Description and Business Overview
Table 69. GlaxoSmithKline Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. GlaxoSmithKline Oral Anti-allergic Drugs Product
Table 71. GlaxoSmithKline Recent Development
Table 72. Bayer Company Information
Table 73. Bayer Description and Business Overview
Table 74. Bayer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Bayer Oral Anti-allergic Drugs Product
Table 76. Bayer Recent Development
Table 77. Almirall Company Information
Table 78. Almirall Description and Business Overview
Table 79. Almirall Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Almirall Oral Anti-allergic Drugs Product
Table 81. Almirall Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Description and Business Overview
Table 84. Pfizer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Pfizer Oral Anti-allergic Drugs Product
Table 86. Pfizer Recent Development
Table 87. AstraZeneca Company Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. AstraZeneca Oral Anti-allergic Drugs Product
Table 91. AstraZeneca Recent Development
Table 92. Sun Pharma Company Information
Table 93. Sun Pharma Description and Business Overview
Table 94. Sun Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Sun Pharma Oral Anti-allergic Drugs Product
Table 96. Sun Pharma Recent Development
Table 97. Novartis Company Information
Table 98. Novartis Description and Business Overview
Table 99. Novartis Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Novartis Oral Anti-allergic Drugs Product
Table 101. Novartis Recent Development
Table 102. Boehringer Ingelheim Company Information
Table 103. Boehringer Ingelheim Description and Business Overview
Table 104. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Boehringer Ingelheim Oral Anti-allergic Drugs Product
Table 106. Boehringer Ingelheim Recent Development
Table 107. UCB Pharma Company Information
Table 108. UCB Pharma Description and Business Overview
Table 109. UCB Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. UCB Pharma Oral Anti-allergic Drugs Product
Table 111. UCB Pharma Recent Development
Table 112. Yangtze River Pharmaceutical Group Company Information
Table 113. Yangtze River Pharmaceutical Group Description and Business Overview
Table 114. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product
Table 116. Yangtze River Pharmaceutical Group Recent Development
Table 117. Hainan Poly Pharm Company Information
Table 118. Hainan Poly Pharm Description and Business Overview
Table 119. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Hainan Poly Pharm Oral Anti-allergic Drugs Product
Table 121. Hainan Poly Pharm Recent Development
Table 122. Chongqing Huapont Pharmaceutical Company Information
Table 123. Chongqing Huapont Pharmaceutical Description and Business Overview
Table 124. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product
Table 126. Chongqing Huapont Pharmaceutical Recent Development
Table 127. Dawnrays Pharma Company Information
Table 128. Dawnrays Pharma Description and Business Overview
Table 129. Dawnrays Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Dawnrays Pharma Oral Anti-allergic Drugs Product
Table 131. Dawnrays Pharma Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Oral Anti-allergic Drugs Customers List
Table 135. Oral Anti-allergic Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Anti-allergic Drugs Product Picture
Figure 2. Global Oral Anti-allergic Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Oral Anti-allergic Drugs Market Size 2018-2034 (US$ Million)
Figure 4. Global Oral Anti-allergic Drugs Sales 2018-2034 (K Units)
Figure 5. United States Oral Anti-allergic Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Oral Anti-allergic Drugs Market Size 2018-2034 (US$ Million)
Figure 7. United States Oral Anti-allergic Drugs Sales 2018-2034 (K Units)
Figure 8. United States Oral Anti-allergic Drugs Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Oral Anti-allergic Drugs Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Oral Anti-allergic Drugs Report Years Considered
Figure 11. Product Picture of Antihistamine Drugs
Figure 12. Product Picture of Allergic Mediator Release Agent
Figure 13. Product Picture of Immunosuppressant Drugs
Figure 14. Global Oral Anti-allergic Drugs Market Share by Type in 2024 & 2034
Figure 15. Global Oral Anti-allergic Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Oral Anti-allergic Drugs Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 18. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Oral Anti-allergic Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 20. United States Oral Anti-allergic Drugs Market Share by Type in 2024 & 2034
Figure 21. United States Oral Anti-allergic Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. United States Oral Anti-allergic Drugs Sales Market Share in Value by Type (2018-2034)
Figure 23. United States Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 24. United States Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 25. United States Oral Anti-allergic Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Hospital Pharmacies
Figure 27. Product Picture of Retail Pharmacies
Figure 28. Product Picture of Online Pharmacies
Figure 29. Global Oral Anti-allergic Drugs Market Share by Application in 2024 & 2034
Figure 30. Global Oral Anti-allergic Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 31. Global Oral Anti-allergic Drugs Sales Market Share in Value by Application (2018-2034)
Figure 32. Global Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 33. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 34. Global Oral Anti-allergic Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 35. United States Oral Anti-allergic Drugs Market Share by Application in 2024 & 2034
Figure 36. United States Oral Anti-allergic Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 37. United States Oral Anti-allergic Drugs Sales Market Share in Value by Application (2018-2034)
Figure 38. United States Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 39. United States Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 40. United States Oral Anti-allergic Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 41. Americas Oral Anti-allergic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 42. Americas Oral Anti-allergic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 43. Americas Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 44. Americas Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 45. Americas Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 46. Americas Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 47. United States Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Canada Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Mexico Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. EMEA Oral Anti-allergic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 52. EMEA Oral Anti-allergic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 53. EMEA Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 54. EMEA Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 55. EMEA Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 56. EMEA Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 57. Europe Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Africa Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. China Oral Anti-allergic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 61. China Oral Anti-allergic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 62. China Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 63. China Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 64. China Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 65. China Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 66. APAC Oral Anti-allergic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 67. APAC Oral Anti-allergic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 68. APAC Oral Anti-allergic Drugs Sales by Type (2018-2034) & (K Units)
Figure 69. APAC Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 70. APAC Oral Anti-allergic Drugs Sales by Application (2018-2034) & (K Units)
Figure 71. APAC Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 72. Japan Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. South Korea Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. China Taiwan Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. India Oral Anti-allergic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Oral Anti-allergic Drugs Value Chain
Figure 78. Oral Anti-allergic Drugs Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries